Patents by Inventor Concepcion Sanchez-Martinez

Concepcion Sanchez-Martinez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS USEFUL FOR INHIBITING CDK7
    Publication number: 20230203031
    Abstract: CDK7 inhibitors according to the formula (I): wherein X is —CH(OH)CH3, —CHFCH3, —CF2CH3, or —CF3; Y is —CH?CH2 or C2H?C2H2; and Z is CH(CH3)2 or C2H(CH3)(CH22H), pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods for their use are provided.
    Type: Application
    Filed: May 20, 2021
    Publication date: June 29, 2023
    Inventors: Maria Carmen FERNANDEZ FIGUEROA, Wenceslao LUMERAS AMADOR, Concepcion SANCHEZ-MARTINEZ
  • Protein kinase inhibitors
    Patent number: 7855211
    Abstract: The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt thereof which is useful in the treatment of cell proliferative diseases.
    Type: Grant
    Filed: December 15, 2009
    Date of Patent: December 21, 2010
    Assignee: Eli Lilly and Company
    Inventors: David A Coates, Lawrence Mark Gelbert, John M. Knobeloch, Alfonso De Dios Magana, Ana De Prado Gonzalez, Miriam Filadelfa Del Prado Catalina, Maria Cristina Garcia Paredes, Eva Maria Martin De La Nava, Maria Dolores Martin Ortega Finger, Jose Antonio Martinez Perez, Ana Isabel Mateo Herranz, Carlos Perez Martinez, Concepcion Sanchez Martinez
  • PROTEIN KINASE INHIBITORS
    Publication number: 20100160340
    Abstract: The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt thereof which is useful in the treatment of cell proliferative diseases.
    Type: Application
    Filed: December 15, 2009
    Publication date: June 24, 2010
    Inventors: David A. COATES, Lawrence Mark GELBERT, John M. KNOBELOCH, Alfonso DE DIOS MAGANA, Ana DE PRADO GONZALEZ, Miriam FILADELFA DEL PRADO CATALINA, Maria Cristina GARCIA PAREDES, Eva Maria MARTIN DE LA NAVA, Maria Dolores MARTIN ORTEGA FINGER, Jose Antonio MARTINEZ PEREZ, Ana Isabel MATEO HERRANZ, Carlos PEREZ MARTINEZ, Concepcion SANCHEZ MARTINEZ
  • KINASE INHIBITORS
    Publication number: 20090318443
    Abstract: The present invention provides kinase inhibitors of Formula I.
    Type: Application
    Filed: July 27, 2009
    Publication date: December 24, 2009
    Inventors: Rosanne Bonjouklian, Chafiq Hamdouchi Hamdouchi, Chuan Shih, Alfonso De Dios, Miriam Filadelfa Del Prado, Carlos Jaramillo Aguado, Pramila Kotiyan, Mary Margaret Mader, Sheila Pleite Selgas, Concepcion Sanchez-Martinez
  • Kinase inhibitors
    Patent number: 7582652
    Abstract: The present invention provides kinase inhibitors of Formula I.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: September 1, 2009
    Assignee: Eli Lilly and Company
    Inventors: Rosanne Bonjouklian, Chafiq Hamdouchi, Chuan Shih, Alfonso De Dios, Miriam Filadelfa del Prado, Carlos Jaramillo Aguado, Pramila Kotiyan, Mary Margaret Mader, Sheila Pleite Selgas, Concepcion Sanchez-Martinez
  • KINASE INHIBITORS
    Publication number: 20090036445
    Abstract: The present invention provides kinase inhibitors of Formula I.
    Type: Application
    Filed: January 25, 2005
    Publication date: February 5, 2009
    Inventors: Rosanne Bonjouklian, Chafiq Hamdouchi, Chuan Shih, Alfonso De Dios, Miriam Filadelfa del Prado, Carlos Jaramillo Aguado, Pramila Kotiyan, Mary Margaret Mader, Sheila Pleite Selgas, Concepcion Sanchez-Martinez
  • Benzimidazoles and benzothiazoles as inhibitors of map kinase
    Patent number: 7320995
    Abstract: The present invention provides kinase inhibitors of Formula I: wherein W represents inter alia imidazol, oxazol, pyrazol, thiazol as triazol, which are substituted by phenyl or thienyl.
    Type: Grant
    Filed: July 31, 2003
    Date of Patent: January 22, 2008
    Assignee: Eli Lilly and Company
    Inventors: Rosanne Bonjouklian, Jose Eugenio De Diego Gomez, Alfonso De Dios, Chafiq Hamdouchi Hamdouchi, Tiecho Li, Beatriz Lopez De Uralde Garmendia, Michal Vieth, Jeremy Schulenberg York, Robert Dean Dally, Miriam Filadelfa Del Prado Catalina, Carlos Jaramillo Aguado, Luisa Maria Martin-Cabrejas, Carlos Montero Salgado, Sheila Pleite Selgas, Concepcion Sanchez-Martinez, Timothy Alan Shepherd, James Howard Wikel
  • Methods and compounds for treating proliferative diseases
    Patent number: 7109229
    Abstract: The compounds disclosed herein are indolocarbazoles of Formula (I), which are potent CDK4 inhibitors, and are useful in the treatment of cell proliferative disorders, including cancer. Formula (I).
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: September 19, 2006
    Assignee: Eli Lilly and Company
    Inventors: Thomas Albert Engler, Kelly Wayne Furness, Sushant Malhotra, Stephen Lyle Briggs, Harold Burns Brooks, David K yes Clawson, Concepcion Sanchez-Martinez, Faming Zhang, Guoxin Zhu
  • Benzimidazoles and benzothiazoles as inhibitors of map kinase
    Publication number: 20050272791
    Abstract: The present invention provides kinase inhibitors of Formula I: wherein W represents inter alia imidazol, oxazol, pyrazol, thiazol as triazol, which are substituted by phenyl or thienyl. The disclosed compounds inhibit p-38 kinase and are useful in the treatment of metastasis or rheumatoid arthritis.
    Type: Application
    Filed: July 31, 2003
    Publication date: December 8, 2005
    Applicant: Eil Lilly and Company
    Inventors: Rosanne Bonjouklian, Jose De Diego Gomez, Alfonso De Dios, Chafiq Hamdouchi, Tiecho Li, Beatriz De Uralde Garmendia, Michal Vieth, Jeremy York, Robert Dally, Miriam Del Prado Catalina, Carlos Jaramillo Aguado, Luisa Martin-Cabrejas, Carlos Montero Salgado, Sheila Pleite Selgas, Concepcion Sanchez-Martinez, Timothy Shepherd, James Wikel
  • Methods and compounds for treating proliferative diseases
    Publication number: 20040048915
    Abstract: The compounds disclosed herein are indolocarbazoles of Formula (I), which are potent CDK4 inhibitors, and are useful in the treatment of cell proliferative disorders, including cancer. Formula (I).
    Type: Application
    Filed: February 7, 2003
    Publication date: March 11, 2004
    Inventors: Thomas Albert Engler, Kelly Wayne Furness, Sushant Malhotra, Stephen Lyle Briggs, Harold Burns Brooks, David Keyes Clawson, Concepcion Sanchez-Martinez, Faming Zhang, Guoxin Zhu
  • Spirocyclic C-glycosides
    Patent number: 6069238
    Abstract: An improved and a new synthetic route for the reparation of spirocyclic C-glycoside compounds having the following general structure are described. ##STR1## Novel derivatives of spirocyclic C-glycoside compounds are also disclosed which may be used as intermediates in the synthesis and evaluation of potential pharmaceutically active materials.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: May 30, 2000
    Assignee: Eli Lilly and Company
    Inventors: Stephen Andrew Hitchcock, Chafiq Hamdouchi, Concepcion Sanchez-Martinez, Almudena Rubio Esteban